Insider · CIK 0001250757

DAVIDSON EUGENE A

Reports to the SEC for 1 company · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001250757

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-01-18	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+4,297 sh	—	—	71,763
2010-01-26	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+4,716 sh	—	—	45,066
2009-03-02	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,850 sh	—	—	32,850
2009-03-02	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+7,500 sh	—	—	40,350
2008-02-01	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,850 sh	—	—	2,850
2005-05-26	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.13	+$31.3K	40,000
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$15.16	−$3,032	39,800
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$15.14	−$3,028	39,600
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$15.13	−$1,513	39,500
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−600 sh	$15.12	−$9,072	38,900
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$15.11	−$1,511	38,800
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−1,037 sh	$15.10	−$15.7K	37,763
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$15.09	−$1,509	37,663
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$15.03	−$1,503	37,563
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−63 sh	$15.01	−$945.63	37,500
2005-05-26	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−7,500 sh	$15.00	−$113K	30,000
2005-05-26	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	—	—	0
2005-04-25	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Purchase)A Award	Director	AAward	+1,275 sh	$14.33	+$18.3K	1,275
2004-04-23	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$2.63	+$65.6K	53,980
2004-04-23	ANIKAnika Therapeutics, Inc.S Sale	Director	SSale	−24K sh	$9.31	−$223K	30,000
2004-04-23	ANIKAnika Therapeutics, Inc. · Stock option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$2.63	+$65.6K	55,926

Recent filings

Accepted (ET)
Jan 204
DAVIDSON EUGENE A0001140361-11-003524
SEC(opens sec.gov)
Jan 284
DAVIDSON EUGENE A0001140361-10-002944
SEC(opens sec.gov)
Mar 34
DAVIDSON EUGENE A0001104659-09-013954
SEC(opens sec.gov)
Feb 54
DAVIDSON EUGENE A0001104659-08-007367
SEC(opens sec.gov)
May 274
DAVIDSON EUGENE A0001250757-05-000002
SEC(opens sec.gov)
Apr 274
ANIKA THERAPEUTICS INC0001250757-05-000001
SEC(opens sec.gov)
Apr 264
DAVIDSON EUGENE A0001250757-04-000001
SEC(opens sec.gov)

Companies

Anika Therapeutics, Inc.DirectorANIK

Address

32 WIGGINS AVENUE

BEDFORD, MA, 01730